These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 24040780)
1. Pericytes and renal microvascular disease induce renal fibrosis in CKD. Futrakul N; Deekajorndech T; Futrakul P Clin Nephrol; 2013 Oct; 80(4):310. PubMed ID: 24040780 [No Abstract] [Full Text] [Related]
2. The role played by perivascular cells in kidney interstitial injury. Rojas A; Chang FC; Lin SL; Duffield JS Clin Nephrol; 2012 May; 77(5):400-8. PubMed ID: 22551886 [TBL] [Abstract][Full Text] [Related]
3. Biology of the renal pericyte. Smith SW; Chand S; Savage CO Nephrol Dial Transplant; 2012 Jun; 27(6):2149-55. PubMed ID: 22555252 [TBL] [Abstract][Full Text] [Related]
4. Pivotal role of pericytes in kidney fibrosis. Kida Y; Duffield JS Clin Exp Pharmacol Physiol; 2011 Jul; 38(7):467-73. PubMed ID: 21517936 [TBL] [Abstract][Full Text] [Related]
5. Kidney pericytes: a novel therapeutic target in interstitial fibrosis. Smith SW; Schrimpf C; Parekh DJ; Venkatachalam M; Duffield JS Histol Histopathol; 2012 Dec; 27(12):1503-14. PubMed ID: 23059881 [TBL] [Abstract][Full Text] [Related]
6. Novel insights into pericyte-myofibroblast transition and therapeutic targets in renal fibrosis. Chang FC; Chou YH; Chen YT; Lin SL J Formos Med Assoc; 2012 Nov; 111(11):589-98. PubMed ID: 23217594 [TBL] [Abstract][Full Text] [Related]
7. Renal ischemia-reperfusion induces a dysbalance of angiopoietins, accompanied by proliferation of pericytes and fibrosis. Khairoun M; van der Pol P; de Vries DK; Lievers E; Schlagwein N; de Boer HC; Bajema IM; Rotmans JI; van Zonneveld AJ; Rabelink TJ; van Kooten C; Reinders ME Am J Physiol Renal Physiol; 2013 Sep; 305(6):F901-10. PubMed ID: 23825073 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of Renal Fibrosis. Humphreys BD Annu Rev Physiol; 2018 Feb; 80():309-326. PubMed ID: 29068765 [TBL] [Abstract][Full Text] [Related]
9. Pericytes in the renal vasculature: roles in health and disease. Shaw I; Rider S; Mullins J; Hughes J; Péault B Nat Rev Nephrol; 2018 Aug; 14(8):521-534. PubMed ID: 29942044 [TBL] [Abstract][Full Text] [Related]
10. Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease. Matsumoto Y; Ueda S; Yamagishi S; Matsuguma K; Shibata R; Fukami K; Matsuoka H; Imaizumi T; Okuda S J Am Soc Nephrol; 2007 May; 18(5):1525-33. PubMed ID: 17409314 [TBL] [Abstract][Full Text] [Related]
11. Endothelial sirtuin 1 inactivation enhances capillary rarefaction and fibrosis following kidney injury through Notch activation. Kida Y; Zullo JA; Goligorsky MS Biochem Biophys Res Commun; 2016 Sep; 478(3):1074-9. PubMed ID: 27524235 [TBL] [Abstract][Full Text] [Related]
12. Genetic Deletion of the Stromal Cell Marker CD248 (Endosialin) Protects against the Development of Renal Fibrosis. Smith SW; Croft AP; Morris HL; Naylor AJ; Huso DL; Isacke CM; Savage CO; Buckley CD Nephron; 2015; 131(4):265-77. PubMed ID: 26633297 [TBL] [Abstract][Full Text] [Related]
13. Brief review of the morphology of ciclosporin nephropathy. Mihatsch MJ; Thiel G; Ryffel B Contrib Nephrol; 1986; 51():156-61. PubMed ID: 3552414 [No Abstract] [Full Text] [Related]
14. Activation of pericytes: recent insights into kidney fibrosis and microvascular rarefaction. Fligny C; Duffield JS Curr Opin Rheumatol; 2013 Jan; 25(1):78-86. PubMed ID: 23196325 [TBL] [Abstract][Full Text] [Related]